Fibrosis: all 1,270 studies
Page 3 of 13. Open to participants first (276), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic TreatmentsRecruitingNCT05769868Phase 3
- Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLDRecruitingNCT05766449
- An Observational Study of Patients With Chronic Liver DiseaseEnrolling by invitationNCT05744713
- Empagliflozin in Patients With Cirrhosis and AscitesRecruitingNCT05726032Phase 2
- Effect of Modified Complete Decongestive Therapy on Lower Limbs Fibrosis Post CellulitisRecruitingNCT05661123Not applicable
- A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)RecruitingNCT05648214Phase 1/2
- Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesRecruitingNCT05635266
- Prospective Cohort for Early Detection of Liver CancerRecruitingNCT05541601
- Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)RecruitingNCT05531786Phase 1/2
- Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver CirrhoticsRecruitingNCT05490888Phase 1
- Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRIRecruitingNCT05486572Not applicable
- Adverse Outcomes and Mortality in Liver TransplantRecruitingNCT05477277Not applicable
- Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)Not yet recruitingNCT05473325
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerRecruitingNCT05463796
- CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical ResectionRecruitingNCT05433467Not applicable
- Validation of SMS Protocol for HCC Screening in High-risk PatientsEnrolling by invitationNCT05429190
- Sexual Dysfunction in CirrhosisRecruitingNCT05428267Not applicable
- Body Composition Changes After TIPS and Associated Clinical OutcomesRecruitingNCT05420753Early Phase 1
- The Use of Endoscopic Ultrasound-Guided Portal Pressure Measurements to Guide Beta-Blocker Therapy in Patients With Compensated CirrhosisNot yet recruitingNCT05357599Not applicable
- HRS-AKI Treatment With TIPS in Patients With CirrhosisRecruitingNCT05346393Not applicable
- Hepatic and Systemic Hemodynamic Modeling During Liver SurgeryRecruitingNCT05339984Not applicable
- The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on the Immune Function for Cirrhosis PatientsRecruitingNCT05338294Not applicable
- Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver DiseaseRecruitingNCT05330923
- The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on Liver Reserve Function for Cirrhosis PatientsRecruitingNCT05325437Not applicable
- The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis PatientsRecruitingNCT05325424Not applicable
- Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney TransplantationEnrolling by invitationNCT05285878Phase 2
- Analysis of Dermal Fibroblasts and Immune Cells During Systemic SclerosisRecruitingNCT05273138
- HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver DiseaseRecruitingNCT05205954Not applicable
- Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 CirrhosisRecruitingNCT05201404Phase 3
- Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related CoughRecruitingNCT05120934Phase 2
- FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.RecruitingNCT05095714Not applicable
- A Novel Imaging Based Quantitative Model-aided Detection of Portal Hypertension in Patients With Cirrhosis (CHESS2104)Not yet recruitingNCT05068492
- A Novel Spleen-dedicated Stiffness Measured by FibroScan to Evaluate Cirrhotic Portal Hypertension (CHESS2105)Not yet recruitingNCT05052892
- Hepatic Impairment With Cirrhosis Due to Cholestatic Liver DiseaseRecruitingNCT05045482Phase 1
- Safety and Efficacy of Atorvastatin v. Placebo on HCC RiskRecruitingNCT05028829Phase 2
- THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)Not yet recruitingNCT04925362Not applicable
- 68Ga-FAPI PET/CT in Patients With Various Fibrotic DiseaseRecruitingNCT04831034Early Phase 1
- Cirrhosis Registry of Hospitalized PatientsRecruitingNCT04767945
- "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".RecruitingNCT04690972
- EUS Guided Portal-systemic Pressure Gradient MeasurementRecruitingNCT04633356Phase 1/2
- Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in CirrhosisRecruitingNCT04588077Phase 4
- HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular CarcinomaRecruitingNCT04499833Not applicable
- Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue InjuryRecruitingNCT04485286Phase 2
- Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled TrialRecruitingNCT04448028Phase 4
- VACcination of LIver Transplantation CandidatesRecruitingNCT04446832
- The European NAFLD RegistryRecruitingNCT04442334
- PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic StudiesRecruitingNCT04371042
- Effectiveness of Bariatric Surgery for NAFLD/NASHRecruitingNCT04366999
- European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)RecruitingNCT04190849
- Hepatocarcinoma Recurrence on the Liver Study - Part2Not yet recruitingNCT04053231
- Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ TransplantationNot yet recruitingNCT03946852Not applicable
- Study of microRNAs in a Decompensated CirrhosisRecruitingNCT03905746
- Fibro-inflammatory Progression From Acute to Chronic PancreatitisRecruitingNCT03853447
- Effect of Intense Sport Practice in Athletes With Non-ischemic ScarRecruitingNCT03780231
- Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver DiseaseRecruitingNCT03635541
- Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and OutcomeRecruitingNCT03584204
- Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic SteatohepatitisRecruitingNCT03572465
- Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic PatientsRecruitingNCT03506893Not applicable
- A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese PatientsRecruitingNCT03472157Not applicable
- Austrian Registry on Transjugular Intrahepatic Portosystemic ShuntsRecruitingNCT03409263
- Evaluation of HEArt invoLvement in Patients With FABRY DiseaseRecruitingNCT03362164
- Screening At-risk Populations for Hepatic Fibrosis With Non-invasive MarkersRecruitingNCT03308916Not applicable
- Functional Assessment in Liver TransplantationRecruitingNCT03228290
- Novel Tracer Methods to Evaluate Muscle Protein Metabolism in CirrhosisRecruitingNCT03225677
- Quantitative Diagnosis of Liver Fibrosis on Multiparametric MRIEnrolling by invitationNCT03176797Not applicable
- Mechanisms of Malnutrition in Cirrhosis With Portosystemic ShuntingRecruitingNCT03121404
- A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis BRecruitingNCT03108794
- Blood Collection Biorepository for Liver Disease ResearchRecruitingNCT03025074
- Inflammation and Obesity-associated DiseaseRecruitingNCT02322073
- Establishment of NAFLD Cohort and Development of Fibrosis MarkersRecruitingNCT02206841
- Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver DiseaseRecruitingNCT02060565
- Nottingham Community Liver Biomarkers CohortRecruitingNCT02037867
- Genetic Analysis of KeloidsRecruitingNCT01619553
- Carvedilol for Pre-primary Prophylaxis of Esophageal Varices in CirrhosisRecruitingNCT01212250Not applicable
- Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart DiseaseRecruitingNCT01099982
- Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT00373841
- Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver CirrhosisCompletedNCT06478602Phase 3Results posted
- The Efficacy of Aerobic Exercise Training on ANS and Endothelial Function in Compensated CirrhosisCompletedNCT06288828Not applicableResults posted
- A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCKCompletedNCT06269484Phase 2Results posted
- NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis PatientsTerminatedNCT06000748Phase 2/3Results posted
- Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT05938920Phase 2Results posted
- Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®TerminatedNCT05900050Phase 2Results posted
- A Study to Detect Advanced Liver Disease Via AI-enabled ElectrocardiogramCompletedNCT05782283Not applicableResults posted
- Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBCCompletedNCT05239468Phase 2Results posted
- Composition for Treating Cirrhosis and Liver Cancer (SB-1121)CompletedNCT05178303Phase 4Results posted
- A Trial to Improve Quality of Life in People With CirrhosisCompletedNCT05061992Phase 2/3Results posted
- Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver TransplantTerminatedNCT05027425Phase 2Results posted
- VE303 for Treatment of Hepatic Encephalopathy (HE)CompletedNCT04899115Phase 2Results posted
- LIFT Intervention in Liver Transplant CandidatesCompletedNCT04836923Not applicableResults posted
- The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy.CompletedNCT04675775Not applicableResults posted
- Study of Oral Idebenone to Treat Non-Alcoholic SteatohepatitisCompletedNCT04669158Phase 1/2Results posted
- The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19CompletedNCT04619680Phase 4Results posted
- Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBCTerminatedNCT04594694Phase 2Results posted
- Low-Level Laser in Head and Neck Chronic LymphedemaCompletedNCT04482855Not applicableResults posted
- Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH CirrhosisTerminatedNCT04365868Phase 2/3Results posted
- Hepatocellular Carcinoma Surveillance in CirrhoticsCompletedNCT04248816Not applicableResults posted
- Losartan to Improve Hip MicrofractureTerminatedNCT04212650Phase 1/2Results posted
- A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular DegenerationCompletedNCT04200248Phase 2Results posted
- Effect of Probiotics in Non-alcoholic Fatty Liver Disease and SteatohepatitisTerminatedNCT04175392Phase 1/2Results posted
- A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)SuspendedNCT04104321Phase 3Results posted